Viewing Study NCT04081103


Ignite Creation Date: 2025-12-24 @ 7:21 PM
Ignite Modification Date: 2026-01-05 @ 6:36 PM
Study NCT ID: NCT04081103
Status: TERMINATED
Last Update Posted: 2025-07-14
First Post: 2019-08-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries
Sponsor: Glaukos Corporation
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-06-30
Start Date Type: ACTUAL
Primary Completion Date: 2022-02-07
Primary Completion Date Type: ACTUAL
Completion Date: 2022-02-07
Completion Date Type: ACTUAL
First Submit Date: 2019-08-29
First Submit QC Date: None
Study First Post Date: 2019-09-09
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-08-13
Results First Submit QC Date: None
Results First Post Date: 2024-10-23
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-10
Last Update Post Date: 2025-07-14
Last Update Post Date Type: ACTUAL